Skip to main content

Table 1 Inclusion criteria

From: Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients



WHO performance status:

≤ 2

Histologically-proven of primary cancer disease

M1 stage with primary cancer site radically treated with complete response/resection or stable.

No other site of disease in progression (a maximum of 3 lymph node sites of disease to treat)


<5 cm

Abdomen/pelvic site


No previous surgery or RT in the region to treat


Informed consent.